Direct to Patient

iSpeak Blog
Discussion: In the introductory blog, “Direct to Patient: The Basics & Quality Considerations”1 a collaborating team of direct to patient (DtP) sponsors, couriers, CROS, and QPs introduced several direct to patient models for distribution of study...
Features
This article examines patient preferences in one facet of clinical research: the experience related to the use of investigational medicinal products (IMPs). As patients have become more involved and informed in their healthcare choices, the “voice of the patient” has been increasingly incorporated...
iSpeak Blog
Making clinical trials more patient centric is among the many challenges facing the pharmaceutical industry. One method of improving the patient experience is by delivering study medication directly to patient homes, also known as Direct-to-Patient or...
iSpeak Blog
Clinical trials becoming more complex and protocols are more demanding than ever. Long-term participation/commitment and frequent travel to investigator sites is a critical element for patient to decide if they want/can participate in a clinical...